Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Pharmaceutical Filtration
... CAGR of 17.2% over the analysis period 2024-2030. Membrane Filters, one of the segments analyzed in the report, is expected to record a 21.2% CAGR and reach US$19.6 Billion by the end of the analysis ... Read More
-
Pharmaceutical Robots
... CAGR of 7.6% over the analysis period 2024-2030. Traditional Robots, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$224.1 Million by the end of the analysis ... Read More
-
Pharmaceutical Processing Seals
... at a CAGR of 8.2% over the analysis period 2024-2030. O-Rings, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$2.8 Billion by the end of the ... Read More
-
Global Preclinical CRO Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Global Antibiotics Market 2025-2029
... analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, ... Read More
-
Drugs and Medicaments - International Trade in Q4-2024: Top Markets' Performance by Major Competitors
... Drugs and Medicaments recorded a year-over-year increase of +11.2% in $. As regards major competitors of Drugs and Medicaments, in year 2024 Ireland and Italy showed the best results in USD values compared to the ... Read More
-
Pharmaceutical Manufacturing
... US), as well as AstraZeneca and GlaxoSmithKline (both based in the UK), Bayer (Germany), Novartis and Roche (both based in Switzerland), and Sanofi (France). COMPETITIVE LANDSCAPE Pharmaceutical manufacturers compete to discover and commercialize ever-more effective ... Read More
-
Lyophilized Injectable Drugs Global Market Opportunities And Strategies To 2033
... By Indication: Oncology; Infectious Diseases; Autoimmune Diseases; Metabolic Conditions4) By End-User: Hospitals; Ambulatory Surgery Centers (ASCs); Specialty ClinicsCovering: Novartis AG; Pfizer Inc.; Sanofi SA; Baxter International Inc.; Hikma Pharmaceuticals plc Lyophilized Injectable Drugs Global Market ... Read More
-
African Pharmaceutical Directory 2025
African Pharmaceutical Directory 2025 If you need to source from, or sell to Pharmaceuticals, Biotechnology products, OTC/Healthcare products, Generics, Genomics, or Diagnostics/Reagents the new African Pharmaceutical Directory will provide you with fresh business contacts. Read More
-
European Pharmaceutical Directory 2025
European Pharmaceutical Directory 2025 The most comprehensive and accurate Directory of companies and executives in the pharmaceutical industry throughout South and Central America.Extensive profiles of companies and each company's senior officials. Read More
-
Directory of Pharmaceutical Venture Capital & Private Equity Firms 2025
... Firms 2025 This useful resource brings together both venture capital & private equity investors involved in pharmaceuticals. This Edition has been extensively updated, offering valuable, current, & detailed information to individuals, entrepreneurs, & businesses worldwide. Read More
-
Middle East Pharmaceutical Directory 2025
... Directory 2025 The market potential of the Middle East pharmaceutical & biotechnology sector is enormous & business opportunities abound. However, unravelling the maze of is a daunting task. Here's the solution you're been looking for. Read More
-
USA Pharmaceutical Directory 2025
... Directory 2025 The Directory is one of the most comprehensive & accurate Directory of companies & executives in the USA pharmaceutical industry. This powerful Directory is your connection to key decision-makers in the pharmaceutical industry. Read More
-
South and Central American Pharmaceutical Directory 2025
... South & Central America, this directory is essential for you. Where else will you find such a broad depth of both key contact & production information for the pharmaceutical industry in one handy reference source? Read More
-
Asian Pharmaceutical Directory 2025
Asian Pharmaceutical Directory 2025 The most comprehensive and accurate Directory of companies and executives in the pharmaceutical industry throughout Asia.Extensive profiles of companies and each company's senior officials. Read More
-
Active Pharmaceutical Ingredients Directory 2025
... Directory 2025 The Active Pharmaceutical Ingredients Directory contains corporate information, senior executives, contact details email addresses of those working in every segment of the API marketplace, & includes important information on manufacturers, distributors & agencies. Read More
-
International Directory of Pharmaceutical Companies 2025
... of Pharmaceutical Companies 2025 The most comprehensive and accurate Directory of companies and executives in the pharmaceutical industry Internationally. Ideal for Marketers and those seeking new opportunities.Extensive profiles of companies and each company's senior officials Read More
-
European and USA Pharmaceutical Directory 2025
... USA Pharmaceutical Directory 2025 This new Directory combines both the European Pharmaceutical Directory & USA Pharmaceutical Directory. The Directory has been thoroughly researched, to bring you a guide to Europe's & America's ever-changing pharmaceutical industries. Read More
-
Pharmaceutical Directory of India 2025
Pharmaceutical Directory of India 2025 The most comprehensive and accurate Directory of companies and executives in the pharmaceutical industry of India.Extensive profiles of companies and each company's senior officials. Read More
-
Pharmaceutical Directory of China 2025
... Directory of China 2025 If you need to source from, or sell, if you're looking to break into this appealing market, the new China Pharmaceutical Directory will provide you with thousands of fresh business contacts Read More
-
Financial Analysis and Multi-Year Benchmarking: Collegium Pharmaceutical Inc (COLL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forCollegium Pharmaceutical Inc (COLL:NAS) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ultragenyx Pharmaceutical Inc (RARE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forUltragenyx Pharmaceutical Inc (RARE:NAS) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amphastar Pharmaceutical Inc (AMPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forAmphastar Pharmaceutical Inc (AMPH:NAS) compared to its top competitors and compared to ... Read More
-
Financial Analysis and Multi-Year Benchmarking: West Pharmaceutical Services Inc (WST:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forWest Pharmaceutical Services Inc (WST:NYS) compared to its top competitors ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Catalyst Pharmaceutical Inc (CPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks forCatalyst Pharmaceutical Inc (CPRX:NAS) compared to its top competitors and compared to ... Read More